Danielle M. Brander

Danielle M. Brander, MD

Medical Instructor
Division of Hematologic Malignancies & Cellular Therapy
Department of Medicine
Duke University
Attending Physician, Hematologic Malignancies
Duke University Health System
Durham, North Carolina

Explore Activities by Danielle M. Brander

Title
Format
Credit Type
Credits
Strategies to Mitigate Adverse Events with Asparaginase Treatment in Patients With ALL

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Selecting Therapy for AML Without Predictive Biomarkers or Therapeutically Actionable Genomic or Molecular Alterations

Content Format:

Slideset

Credit Type:

--

Credits:

--
An Interactive Algorithm Tool: Assessment and Management of CAR T-Cell Toxicities

Content Format:

Tool

Credit Type:

--

Credits:

--
Considering the Role of MRD Evaluation for Patients With CLL

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Prognostic Marker Testing in Treatment-Naive Patients With CLL—Still Important

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 1

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 3

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 2

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors

Content Format:

Video

Credit Type:

AMA

Credits:

1.50
ExpressPoints Chronic Lymphocytic Leukemia: New Horizons with BTK Inhibitors

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
BTK Inhibitors in Treatment-Naive CLL

Content Format:

Slideset Download

Credit Type:

--

Credits:

--